| 000 | 01807 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518073340.0 | ||
| 264 | 0 | _c20200929 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1872-7905 | ||
| 024 | 7 |
_a10.1016/j.jim.2019.112711 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLhomme, Edouard | |
| 245 | 0 | 0 |
_aAnalyzing cellular immunogenicity in vaccine clinical trials: a new statistical method including non-specific responses for accurate estimation of vaccine effect. _h[electronic resource] |
| 260 |
_bJournal of immunological methods _c02 2020 |
||
| 300 |
_a112711 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAIDS Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBenchmarking |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aDatasets as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFlow Cytometry _xstandards |
| 650 | 0 | 4 |
_aHIV Infections _ximmunology |
| 650 | 0 | 4 |
_aHIV-1 _ximmunology |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Cellular |
| 650 | 0 | 4 | _aImmunogenicity, Vaccine |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xstandards |
| 650 | 0 | 4 |
_aResearch Design _xstandards |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHejblum, Boris P | |
| 700 | 1 | _aLacabaratz, Christine | |
| 700 | 1 | _aWiedemann, Aurélie | |
| 700 | 1 | _aLelièvre, Jean-Daniel | |
| 700 | 1 | _aLevy, Yves | |
| 700 | 1 | _aThiébaut, Rodolphe | |
| 700 | 1 | _aRichert, Laura | |
| 773 | 0 |
_tJournal of immunological methods _gvol. 477 _gp. 112711 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jim.2019.112711 _zAvailable from publisher's website |
| 999 |
_c30393708 _d30393708 |
||